Hum. Reprod. Advance Access published online on November 26, 2004
Human Reproduction, doi:10.1093/humrep/deh602
© 2004 by European Society of Human Reproduction and Embryology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Clínica de Medicina de la Reproducción y Ginecología ‘FIVMadrid’, Madrid, Spain
* To whom correspondence should be addressed. BACKGROUND: We aimed to assess the efficacy of a GnRH antagonist in intrauterine insemination (IUI) cycles to increase number of mature ovulatory follicles and pregnancy rates. METHODS: Prospective randomized study. Women (18-38 years old) with primary/secondary infertility were included. Eighty-two patients were randomly assigned to controlled ovarian stimulation (COS) consisting of rFSH + GnRH antagonist or rFSH alone. RESULTS: A non-significant increase in the total amount of rFSH was seen in the GnRH antagonist group (707±240 IU) with respect to the control group (657±194 IU). The number of mature follicles (
Revised August 6, 2004
Accepted October 15, 2004
Article
Timing ovulation for intrauterine insemination with a GnRH antagonist
2 Unidad de Reproducción, Hospital ‘Severo Ochoa’, Madrid, Spain
E.R. Hernández, E-mail: ehernandezm{at}fivmadrid.es
![]()
Abstract
16 mm) was significantly higher in the GnRH antagonist group than in the control group (2.4±1.4 versus 1.7±1.2, P<0.05). Pregnancy rates were significantly increased in the group of patients receiving the GnRH antagonist (38%) compared to the control group (14%). The only non-single pregnancy (triplets) occurred in the antagonist group. CONCLUSIONS: In this preliminary study, adding the GnRH antagonist to the COS protocol for IUI cycles significantly increased pregnancy rates. Nevertheless, these results may not be associated directly with the antagonist itself but with the fact that more mature ovulatory follicles are present by the day of the hCG. Finally, the risk for multiple gestations needs to be carefully evaluated.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
The ESHRE Capri Workshop Group Intrauterine insemination Hum. Reprod. Update, May 1, 2009; 15(3): 265 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.G. Crosignani, E. Somigliana, and on behalf of the Intrauterine Insemination (IUI) S Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial Hum. Reprod., February 1, 2007; 22(2): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Allegra, A. Marino, F. Coffaro, P. Scaglione, F. Sammartano, G. Rizza, and A. Volpes GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial Hum. Reprod., January 1, 2007; 22(1): 101 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, P. Devroey, and , On Behalf of the Brussels GnRH Antagonist Consen GnRH antagonists in ovarian stimulation for IVF Hum. Reprod. Update, July 1, 2006; 12(4): 333 - 340. [Abstract] [Full Text] [PDF] |
||||

